A Novel Computer Assisted Genomic Test Method to Detect Breast Cancer in Reduced Cost and Time Using Ensemble Technique

Breast cancer is the leading cause of death among women around the world. It is a primary malignancy for which genetic markers have revealed the ability for clinical decision making. It is a genetic disease that generates due to gene mutations, but the cost of a genetic test is relatively high for a number of patients in developing nations like India. The results of a genetic test can take a few weeks to determine cancer. This time duration influences the prognosis of genes since certain patients suffer from a high rate of malignant cell proliferation. Therefore, a computer-assisted genetic test method (CAGT) is proposed to detect breast cancer. This test method will predict the gene expressions and convert these expressions in the state of mutation- under-expression (-1), transition (0) overexpression (1)-and afterwards perform the classification to get the benign and malignant class in reduced time and cost. In the research work, machine learning techniques are applied to identify the most responsive genes of breast cancer on the premises of the clinical report of a patient and generated a CAGT. In the research work, the hard voting ensemble approach is applied to detect breast cancer on the basis of most responsive genes by CAGT which leads to improving 3.5% accuracy in cancer classification.

Automated summary

Breast cancer, a leading cause of death for women worldwide, can be detected through genetic markers. However, the high cost of genetic tests in developing countries like India prevents many patients from accessing timely diagnosis. To address this issue, a computer-assisted genetic test method (CAGT) is proposed to predict gene expressions and classify breast cancer in a faster and more cost-effective manner.